Naoto Uemura
Oita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Water intake during drinking does not alleviate hangover symptoms.
Journal: Frontiers in pharmacology
Published: April 10, 2026
Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024).
Journal: Clinical and translational science
Published: March 18, 2026
Current Status of Generative Artificial Intelligence Utilization in Medical Education: A Cross-Sectional Survey of Medical Students and Faculty.
Journal: JMA journal
Published: December 27, 2025
Utility of Modeling and Simulations in Drug Development: Contrasting Japan, US and UK Descriptions of PBPK Modeling from Package Inserts.
Journal: The AAPS journal
Published: November 26, 2025
Fixed Versus Lottery Incentives for Promoting Engagement With a Cadence-Based Smartphone App: Randomized Crossover Trial.
Journal: JMIR formative research
Published: October 22, 2025
Clinical performance of the multiplex solid-phase "Direct Strip PCR" for infectious uveitis: a multicenter diagnostic accuracy study.
Journal: Japanese journal of ophthalmology
Published: September 16, 2025
Forensic implications of ethyl glucuronide and ethyl sulfate pharmacokinetics in Japanese adults: the influence of dose, genetic polymorphisms, and habitual alcohol consumption.
Journal: Forensic toxicology
Published: September 10, 2025
Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 31, 2025
Correction: Assessing Immunogenicity in Drug Reviews and Prescribing Information in Japan.
Journal: The AAPS journal
Published: February 12, 2025
Assessing Immunogenicity in Drug Reviews and Prescribing Information in Japan.
Journal: The AAPS journal
Published: July 02, 2024
Safety, pharmacokinetics, and pharmacodynamics of ART-648, a PDE4 inhibitor in healthy subjects: A randomized, placebo-controlled phase I study.
Journal: Clinical and translational science
Published: June 02, 2024
Last Updated: 09/26/2026